FIRST LIGHT ASSET MANAGEMENT LLC
Q1 2025 Form 13-F
EDINA, MINNESOTA
CIK 0001600004
· CRD 168899
· SEC-registered investment adviser
$875.7M Reported Value Total
FIRST LIGHT ASSET MANAGEMENT, LLC reports 1,077 total accounts under management (AUM). There are 1,077 discretionary accounts valued at $1,131,174,724, and 0 non-discretionary accounts.
Source: Form ADV filed * Note that certain holdings are exempt from Form 13-F reporting, so the AUM totals may be greater than the Form 13-F total.
Private funds (Form ADV)
4 funds
· $1.1B gross asset value
Hedge Fund: $1.1B
Source: Form ADV filed 2026-03-24
Reported value
$875.7M
Quarter over quarter
-9.1%
Holdings
37
Top-10 concentration
62.0%
Filing Structure
Key People
Form ADV owners & control persons
Mathew Paul Arens
MANAGING MEMBER, CEO, & SENIOR PORTFOLIO MANAGER
Brett Thomas Johnson
SENIOR RESEARCH ANALYST & FOUNDING PRINCIPAL
Kurt Terry Peterson
CHIEF FINANCIAL OFFICER & CHIEF COMPLIANCE OFFICER
Filing Navigation
13F Metrics
Loading 13F Metrics
Q1 2025 13F record
Q1 2025 13F filing summary
| Period of report | March 31, 2025 |
|---|---|
| Filed | May 15, 2025 |
| Form | 13F-HR |
| Reported value | $875.7M |
| Positions | 37 |
| Change in reported value | -16.2% |
| New positions | 6 |
| Exited positions | 5 |
| Position turnover | 26.2% |
| Top-10 concentration | 62.0% |
13F filings by quarter
| Quarter | Positions | Value |
|---|---|---|
|
Q3 2026 13F
Filed Nov 16, 2026
|
32 | $1.7B |
|
Q2 2026 13F
Filed Aug 14, 2026
|
31 | $1.6B |
|
Q1 2026 13F
Filed May 15, 2026
|
35 | $1.1B |
|
Q4 2025 13F
Filed Feb 17, 2026
|
33 | $1.3B |
|
Q3 2025 13F
Filed Nov 14, 2025
|
41 | $1.1B |
|
Q2 2025 13F
Filed Aug 14, 2025
|
38 | $771.3M |
|
Q1 2025 13F
Filed May 15, 2025
|
37 | $875.7M |
|
Q4 2024 13F
Filed Feb 14, 2025
|
36 | $1.0B |
|
Q3 2024 13F
Filed Nov 14, 2024
|
38 | $1.2B |
|
Q2 2024 13F
Filed Aug 14, 2024
|
44 | $1.1B |
|
Q1 2024 13F
Filed May 15, 2024
|
50 | $1.3B |
|
Q4 2023 13F
Filed Feb 14, 2024
|
75 | $1.2B |
|
Q3 2023 13F
Filed Nov 14, 2023
|
75 | $1.1B |
|
Q2 2023 13F
Filed Aug 14, 2023
|
79 | $1.3B |
|
Q1 2023 13F
Filed May 15, 2023
|
74 | $1.1B |
|
Q4 2022 13F
Filed Feb 14, 2023
|
74 | $1.1B |
|
Q3 2022 13F
Filed Nov 14, 2022
|
71 | $988.1M |
|
Q2 2022 13F
Filed Aug 12, 2022
|
71 | $859.4M |
|
Q1 2022 13F
Filed May 13, 2022
|
75 | $1.1B |
|
Q4 2021 13F
Filed Feb 14, 2022
|
79 | $1.4B |
32 earlier quarters on file — choose one from the quarter menu above.
Top 20 holdings · Q1 2025
| # | Holding | Reported value | % of portfolio |
|---|---|---|---|
| 1 | ANAB ANAPTYSBIO INC | $86.1M | 9.84% |
| 2 | AXGN AXOGEN INC | $82.8M | 9.45% |
| 3 | CNTA CENTESSA PHARMACEUTICALS PLC | $70.1M | 8.0% |
| 4 | NEO NEOGENOMICS INC | $57.3M | 6.55% |
| 5 | TWST TWIST BIOSCIENCE CORP | $47.8M | 5.46% |
| 6 | HCAT HEALTH CATALYST INC | $47.3M | 5.4% |
| 7 | ATRC ATRICURE INC | $42.4M | 4.84% |
| 8 | EWTX EDGEWISE THERAPEUTICS INC | $40.8M | 4.65% |
| 9 | PFMT PERFORMANT FINL CORP | $34.6M | 3.95% |
| 10 | IRTC IRHYTHM TECHNOLOGIES INC | $34.0M | 3.89% |
| 11 | CRNX CRINETICS PHARMACEUTICALS IN | $28.7M | 3.28% |
| 12 | VERA VERA THERAPEUTICS INC | $28.2M | 3.23% |
| 13 | MDXG MIMEDX GROUP INC | $26.2M | 3.0% |
| 14 | RARE ULTRAGENYX PHARMACEUTICAL IN | $22.9M | 2.61% |
| 15 | SIBN SI-BONE INC | $22.6M | 2.58% |
| 16 | XENE XENON PHARMACEUTICALS INC | $21.1M | 2.41% |
| 17 | NPCE NEUROPACE INC | $19.5M | 2.22% |
| 18 | ALHC ALIGNMENT HEALTHCARE INC | $17.8M | 2.03% |
| 19 | JANX JANUX THERAPEUTICS INC | $17.8M | 2.03% |
| 20 | ESTA ESTABLISHMENT LABS HLDGS INC | $13.7M | 1.57% |
Values as reported on the Q1 2025 Form 13F. Every position is in the holdings table below.